Latest News about FDA
Recent news which mentions FDA
First Patient Dosed in Phase 2 Study of Intercept's OCA and Bezafibrate Combination for Primary Biliary Cholangitis
May 11, 2022
Tickers
ICPT
From Benzinga
From Benzinga
FDA Clears Regulus Therapeutics' IND for RGLS8429 In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
May 11, 2022
Tickers
RGLS
From Benzinga
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
May 11, 2022
From Benzinga
Eli Lilly's Olumiant Becomes First FDA Approved Immunomodulatory Treatment For COVID-19
May 11, 2022
Tickers
LLY
From Benzinga
Arcellx Doses First Patient in Phase 1 study of ACLX-001 in Relapsed or Refractory Multiple Myeloma
May 10, 2022
Tickers
ACLX
From Benzinga
FDA Extends Review Of Amicus Therapeutics' AT-GAA For The Treatment Of Pompe Disease By Three Months
May 10, 2022
Tickers
FOLD
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Achilles Therapeutics Doses First Patient with Higher-dose cNeT in CHIRON Phase 1/2a Trial for Advanced NSCLC
May 09, 2022
Tickers
ACHL
From Benzinga
LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial
May 09, 2022
Tickers
LOGC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.